Human T-lymphotropic virus type 1 (HTLV-1), the etiologic agent of adult T-cell leukemia/lymphoma, is transmitted through breast milk and seminal fluid, which are rich in prostaglandins (PGs). We demonstrate that PGE 2 upregulates the HTLV-1 long terminal repeat promoter through the protein kinase A pathway, induces replication of HTLV-1 in peripheral blood mononuclear cells (PBMC) derived from asymptomatic carriers, and enhances transmission of HTLV-1 to cord blood mononuclear cells (CBMC). Furthermore, HTLV-1 Tax transactivates a promoter for cyclooxygenase 2, a PG synthetase, and induces PGE 2 expression in PBMC or CBMC. Thus, HTLV-1 interacts with and benefits from PGs, constituents of its own vehicle for transmission.
Human T-lymphotropic virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia/lymphoma and is transmitted horizontally or vertically through blood, seminal fluid, or breast milk (reviewed in references 13 and 37).
Prostaglandins (PGs) are synthesized and secreted by most human tissues and cell types; however, they are especially abundant in seminal fluid and breast milk (2, 7, 9, 10) . PGs, particularly those of the E series, are widely regarded as pleiotropic immunomodulatory molecules, and regulation of their expression appears to be critical for a number of immune responses (reviewed in references 26 and 29) . There are two isoforms of cyclooxygenase (COX) that catalyze the formation of PGs from arachidonic acid. While COX-1 is a housekeeping gene that is expressed constitutively, COX-2 is an immediateearly response gene that is highly inducible by mitogenic and inflammatory stimuli and is considered essential for the induction of the aforementioned immune responses (reviewed in reference 32) .
In this study we demonstrate that (i) PGE 2 upregulates the HTLV-1 long terminal repeat (LTR) promoter through the protein kinase A (PKA) pathway, induces viral replication in peripheral blood mononuclear cells (PBMC) derived from asymptomatic HTLV-1 carriers, and enhances transmission of HTLV-1 to cord blood mononuclear cells (CBMC) and that (ii) HTLV-1 Tax transactivates a COX-2 promoter and induces PGE 2 production in PBMC. These data suggest that HTLV-1 interacts with and benefits from PGs that are abundant in seminal fluid and breast milk, vehicles for virus transmission.
MATERIALS AND METHODS
Reagents. PGE 2 , H7, HA-1004, mitomycin C (MMC), 3Ј-azido-3Ј-deoxythymidine (AZT), phorbol 12-myristate 13-acetate (PMA), and ionomycin were purchased from Sigma (St. Louis, Mo.). MMC treatment of cells was performed as described previously (1) .
Infectious HTLV-1 stock which was rendered devoid of cell culture supernatants by directly pelleting virions was obtained from Advanced Biotechnologies, Inc. (Columbia, Md.). Glutathione S-transferase (GST) and GST-Tax protein were propagated as described previously (23) .
Plasmids and transient-expression assays. pU3R-luc, a generous gift of K.-T. Jeang (National Institute of Allergy and Infectious Diseases [NIAID], Bethesda, Md.), carries the luciferase gene under the control of the HTLV-1 LTR. Plasmids pMT-2T (parent plasmid), pMT-Tax (encoding HTLV-1 Tax), pMT-p65 (encoding a NF-B p65 subunit), and pMT-IB (encoding I-B␣) were kindly provided by U. Siebenlist (NIAID) (23) . The human COX-2 promoter-luciferase reporter plasmids phPES(Ϫ1432/ϩ59), phPES(Ϫ327/ϩ59), phPES(Ϫ220/ϩ59), phPES(Ϫ124/ϩ59), phPES(Ϫ52/ϩ59), phPES-KBM (with a mutation at the NF-B site), phPES-ILM (with a mutation at the NF-IL6 site), phPES-CRM (with a mutation at the cyclic AMP-responsive element [CRE]), phPES-KBM/ ILM (with mutations at both the NF-B and NF-IL6 sites), phPES-KBM/CRM (with mutations at both the NF-B site and the CRE), phPES-ILM/CRM (with mutations at both the NF-IL6 site and the CRE), and phPES-KBM/ILM/CRM (with mutations at all three elements) were described previously (14, 15) .
Transfection of the human Jurkat T leukemia cell line or PBMC and luciferase assays for transient-expression assays were performed as described previously (22) . Briefly, 20 million Jurkat cells or 40 million PBMC were transfected by electroporation at 300 or 320 V, respectively, and 975 F with a Gene Pulser II (Bio-Rad, Hercules, Calif.). After electroporation, cells were cultured in RPMI 1640 supplemented with 10% fetal bovine serum (FBS) at 37°C for 40 h. Luciferase activity was determined by using a luciferase assay kit (Promega, Madison, Wis.) with a TD-20e luminometer (Turner).
Measurement of PGE 2 . The concentration of PGE 2 in the cell culture supernatants was determined in triplicate by enzyme-linked immunosorbent assays (ELISA) according to the manufacturer's instructions (R&D Systems, Minneapolis, Minn.). Where indicated, cells were infected with cell-free HTLV-1 stock (1 g of protein per 3 ϫ 10 6 cells) or were treated with GST or GST-Tax at a concentration of 100 ng/ml before cell-free supernatants were collected for PGE 2 measurement.
HTLV-1 infection. For HTLV-1 infection studies, PBMC were obtained from buffy coats of asymptomatic HTLV-1 carriers (Nagasaki Red-Cross Center, Nagasaki, Japan) as described previously (21) . The cells were incubated in 24-well culture dishes at a concentration of 3 ϫ 10 6 per ml in RPMI 1640 supplemented with 10% FBS in the presence or absence of PGE 2 (100 nM).
For HTLV-1 transmission studies, cord blood samples were provided by the Pre-and Post-Natal Care Unit, Nagasaki University School of Medicine Hospital, with consent by donors, and CBMC were cocultured with MMC-treated PBMC obtained from HTLV-1 carriers in the presence or absence of PGE 2 immediately after isolation. Cell-free culture supernatants were collected on day 7 for measurement of HTLV-1 p19 antigen by ELISA (Cellular Products Inc., Buffalo, N.Y.).
RESULTS AND DISCUSSION
PGE 2 upregulates HTLV-1 LTR activity. In order to assess whether PGE 2 could influence expression of HTLV-1, we first performed transient-expression assays. HTLV-1 LTR activity was upregulated by stimulation with PGE 2 in a dose-dependent manner (Fig. 1A) . Since PGE 2 levels in seminal fluid and breast milk whey were reported to be 1 to ϳ70 M (2, 7, 27) and ϳ30 nM (10), respectively, and since an overproduction of PGE 2 (up to 100 M) is seen in a number of medical situations (e.g., allergy, hyper-immunoglobulin E syndrome, Hodgkin's lymphoma, trauma, sepsis, and transplantation) (29), the PGE 2 -mediated effect appears to be physiologically relevant. PGE 2 induction of HTLV-1 LTR activity was markedly abolished by H7 (a selective serine/threonine kinase inhibitor that can inhibit PKA, PKC, and PKG) and HA-1004 (a PKA and PKG inhibitor) ( Fig. 1B and C ). Since PGE 2 has been shown to elevate the level of intracellular cyclic AMP, which activates PKA (27) , it is reasonable to assume that PKA activity is required for transcriptional activity of HTLV-1.
PGE 2 induces HTLV-1 replication. In order to determine whether PGE 2 could actually induce replication of HTLV-1, we incubated PBMC obtained from asymptomatic HTLV-1 carriers in the presence or absence of PGE 2 . Stimulation with PGE 2 enhanced HTLV-1 infection four-to fivefold as determined by HTLV-1 p19 antigen (Ag) levels (Table 1) . Treatment with AZT (2 M) resulted in a markedly decreased expression of p19 Ag (Table 1) . Since AZT has no antiretroviral effect on PBMC already infected with HTLV-1 (18), profound suppression of p19 expression by AZT would indicate that induction of HTLV-1 expression in the presence of PGE 2 required the expansion of HTLV-1 infection. Addition of PGE 2 to the cell culture medium did not appear to influence We next investigated whether PGE 2 could accelerate transmission of HTLV-1 to CBMC. Uninfected CBMC were cocultured with MMC-treated carriers' PBMC at a ratio of 10:1 in the presence or absence of PGE 2 . It has been shown that MMC-treated cells can no longer support new cycles of retroviral infection (1) . As shown in Table 2 , the p19 level in the coculture supernatants was increased by treatment with PGE 2 . PGE 2 treatment increased p19 Ag levels in cultures of MMCtreated carriers' PBMC; however, they were much lower than those in coculture of these cells with CBMC. These results suggest that expansion to susceptible CBMC is required for the induction of HTLV-1 replication. It has been reported that enterally administered milk leukocytes can invade suckling neonates and become distributed in their lymphoid tissues (16, 36) . Therefore, although the exact mechanisms and the target cells in the mucosa of milk-borne infection remain unknown, these results imply that PGE 2 may accelerate viral transmission from maternal lymphocytes in breast milk to neonatal lymphocytes.
HTLV-1 Tax transactivates the COX-2 promoter. As shown above, induction of PGE 2 production is likely to favor HTLV-1 infection and transmission; therefore, we next wanted to investigate whether HTLV-1 infection could influence expression of PGE 2 . The HTLV-1 Tax transactivator has been shown to upregulate expression of a number of viral and cellular genes, which usually contributes to viral replication or transformation (reviewed in references 6, 31, and 35). We therefore tested whether Tax could upregulate promoter activity of COX-2, a PG synthetase. As shown in Fig. 2A , coexpression of Tax alone upregulated the COX-2 promoter-luciferase reporter activity in the Jurkat human T-cell line. Tax alone was a relatively weak transactivator for the COX-2 promoter in PBMC (Fig. 2B) ; however, stimulation with PMA plus ionomycin in addition to Tax synergistically upregulated the COX-2 promoter activity in PBMC (Fig. 2B) . Such synergy has been observed for other Tax-mediated effects (11, 23) . We have also demonstrated that COX-2 promoter activity was upregulated in PBMC treated with purified Tax protein (GST-Tax) (Fig. 2C) .
In order to confirm that HTLV-1 infection or Tax protein induces PGE 2 production, PBMC were infected with HTLV-1 or exposed to purified Tax protein, and PGE 2 levels in the cell culture supernatants were determined by ELISA. HTLV-1-infected cells secrete soluble activity that exerts a number of biological activities on neighboring cells in a paracrine manner, and Tax protein released from infected cells is attributed, at least in part, to the soluble activity (4, 17, 19, 23) . Experiment results listed in Tables 3 and 4 clearly demonstrate that HTLV-1 infection or Tax protein could induce PGE 2 production.
Both NF-B and NF-IL6 sites are required in Tax activation of the COX-2 promoter. HTLV-1 Tax protein is not able to directly bind to DNA; instead, it interacts with certain cellular transcription factors to exert its transregulatory functions (reviewed in references 6, 31, and 35). The COX-2 promoter sequence contains several cis-acting elements (reviewed in ref- -1 stock (0.1 g of protein) . In experiments with PBMC derived from donors D and E, HTLV-1 stock was heat inactivated (56°C, 60 min). PGE 2 levels in the culture supernatants were determined by ELISA on day 7 postinfection. Results are means Ϯ standard errors of the means of triplicate wells. ND, not determined. a A total of 3 ϫ 10 6 PBMC obtained from uninfected volunteers were incubated in the presence of either GST or GST-Tax (100 ng/ml) for 2 days. PGE 2 levels in the culture supernatants were determined by ELISA. Results are means Ϯ standard errors of the means of triplicate wells. erence 38), some of which have been shown to be involved in Tax-mediated transactivation in other promoter contexts. In order to determine the cis-acting elements involved in Taxmediated transactivation of the COX-2 promoter, we tested a number of COX-2 promoter constructs in transient-expression assays. As shown in Fig. 3A , 5Ј truncation of the promoter sequence down to position Ϫ327 modestly reduced responsiveness to Tax activation, while truncation down to Ϫ220 markedly reduced responsiveness. To further delineate the Taxresponsive region in the promoter sequence spanning Ϫ327 to ϩ59 relative to the transcription start site, site-directed mutations were introduced individually or in combination. As shown in Fig. 3B , elements for NF-B (which is located between Ϫ223 and Ϫ214) and for NF-IL6 (which is located between Ϫ132 and Ϫ124) are both involved in Tax-mediated transactivation of the COX-2 promoter: mutation at either of them alone modestly abrogated Tax induction of COX-2 promoter activity, while mutations at both elements markedly abrogated Tax induction of COX-2 promoter activity. In contrast, mutation at the CREB/ATF site (which is located between Ϫ59 and Ϫ53) had little effect on it. Involvement of NF-B in Tax activation of the COX-2 promoter was also investigated by overexpressing I-B␣, a specific inhibitor for NF-B. As expected, while cotransfection of the NF-B p65 expression vector with the COX-2 promoter upregulated the promoter activity, I-B␣ counteracted p65-mediated activation (Fig. 3C) . Similarly, overexpression of I-B␣ markedly abrogated Tax-mediated activation of the COX-2 promoter (Fig. 3C) , suggesting that the NF-B pathway is critical for its effect. Another NF-B site is located between Ϫ1432 and Ϫ327 (H. Inoue and T. Tanabe, unpublished data) and may explain the partial responsiveness of the region to Tax (Fig. 3A) .
In the present study we have demonstrated that HTLV-1, which is transmitted vertically or horizontally through breast milk or seminal fluid, respectively, and PGs, which are abundant in these body fluids, benefit from each other. These results confirm a recent study demonstrating that PKA activity is required for HTLV-1 LTR activity (34) promoter for COX-2, a PG synthetase, leading to production of PGE 2 . Therefore, it is likely that such mutual aid helps accelerate viral transmission through seminal fluid or breast milk. This hypothesis will require experimental evidence.
PGs and other eicosanoids have been shown to play a key role in the regulation of both humoral and cell-mediated immunity, generally tipping the balance in favor of Th2-and Th3-type responses by modulating cytokine and immunoglobulin production as well as T-cell proliferation and activation (reviewed in references 24 and 26). It therefore is not surprising if PGs influence the pathogenesis of infection with a number of pathogens. In fact, recent studies suggested that PGE 2 can modify infection with human immunodeficiency virus type 1, another human retrovirus that is also transmitted through breast milk or seminal fluid (5, 33) . Thus, constituents such as PGs in these body fluids may variably influence viral transmission. We are currently investigating PGE 2 levels in asymptomatic HTLV-1 carriers as well as effects of other constituents in these body fluids on HTLV-1 infection. Preliminary results have indicated that several other constituents also benefit HTLV-1 infection (M. Moriuchi and H. Moriuchi, unpublished data).
Although HTLV-1 has oncogenic potential, the mode of oncogenesis by HTLV-1 is poorly understood. It has been shown that HTLV-1-encoded Tax protein is necessary and sufficient for cell immortalization (reviewed in references 20 and 35). Several studies showed that Tax-transgenic mice develop several types of malignancy, including leukemia, mesenchymal tumors, and neurofibromas (3, 8, 12, 25) . Tax is able to interact with a number of cellular factors involved in transcription and/or cell cycling and is considered to induce cell transformation through such interactions (reviewed in references 20 and 35). Since PGs have also been associated with carcinogenesis (reviewed in reference 30), Tax activation of COX-2 through cellular transcription factors (i.e., NF-B/Rel family proteins) may contribute to HTLV-1-induced oncogenicity. In fact, a recent study has demonstrated that a number of HTLV-1-transformed cell lines do, but most HTLV-1-uninfected cell lines do not, express COX-2 mRNA (N. Mori [Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan], personal communication), implying a critical role in HTLV-1-induced oncogenicity.
In summary, our studies have identified PGs as another target for HTLV-1 Tax, and reciprocal interactions between HTLV-1 and PGs may have implications for its transmission and oncogenesis.
